Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.

		Phase:		Not Specified

		Treatment ID#:		1921

		Age Group:		Pediatric Only

		Min Karnofsky Score:		Not Specified

		Conditions:		Prior Surgery is Sometimes Allowed Prior Radiation is Sometimes Allowed Prior Chemotherapy is Sometimes Allowed Ages 2-17

		Last Updated:		04/22/2009

		Tumor Types:		Anaplastic Astrocytoma Any Malignant Brain Tumor Brainstem Glioma Craniopharyngioma Ependyoma Ganglioglioma Germ Cell Tumors Glioblastoma Multiforme Gliosarcoma Low Grade Glioma Medulloblastoma Metastatic Brain Tumor Mixed Glioma Oligodendroglioma High Grade Oligodendroglioma Low Grade Optic Glioma Pediatric Brain Tumors Pineal Gland Tumor PNET Tumor Recurrent Malignant Pediatric Brain Tumors


		Comments:

		Treatment Type:		Immunological, Biological or Targeted Therapy

		Contact:		NCI Cheryl Royce, CRNP, Clinical Director National Cancer Institute Neuro-oncology Branch 9030 Old Georgetown Road Bethesda, MD 20892 USA Phone: 866-251-9686 Fax: E-mail: roycec@mail.nih.gov Website: home.ccr.cancer.gov/nob/

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By